iqvia glp-1 prescriptions semaglutide tirzepatide q3 2024 prescription trends through June Moby | Novo Nordisk may
Description
Our guide to the Wegovy pill covers how it works in more detail
semaglutide (initially 0.24 mg, then 0.5, 1.0, 1.7, finally 2.4 mg) or placebo (51, 52)
Impact on body weight: GLP-1 receptor activation tends to promote weight loss, while GIP receptor activation may promote weight gain through its effects on fat storage
Case reports, conference abstracts, nonpeer-reviewed sources, and studies lacking clear outcome measures were excluded
Do not double the dose to make up for a missed one
